FDA 483 - MediWound Ltd - November 15, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
MediWound Limited, a drug substance and drug product manufacturer in Yavne, Israel, was cited for significant deficiencies during an FDA inspection. The observations primarily concern inadequate aseptic processing controls, including environmental and personnel monitoring, microbial cross-contamination prevention, and cleaning/sanitization programs. Additionally, the firm's quality oversight, risk assessment for microbial contamination, and qualification of temperature-controlled storage areas were found to be deficient.
ID · c470ab8d-9ffb-45fc-b3ef-ac14c4d3d6e5